Pharmaceuticals, Biotechnology and Life Sciences
Verona Pharma revealed the top-line results from its Phase 2a clinical trial, in which RPL554 was dosed in addition to…
Akers Biosciences has appointed Pamela E. Hibler as its North American commercial team Vice President, Sales and Distribution. Hibler has…
Commenting on the H1 2017 results, Hilde Windels, interim Chief Executive Officer Biocartis (until 31 August 2017), said that the…
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on three Opdivo-based combination clinical studies in…
Vertex Pharmaceuticals Incorporated on Wednesday announced the appointment of Tom Graney as the Senior Vice President and Chief Financial Officer (CFO).
AstraZeneca ob Tuesday announced the appointment of Sheri McCoy and Deborah DiSanzo as Non-Executive Directors of the company. McCoy will also become a member of the Audit Committee.
TiGenix NV has obtained a license for the commercial production of expanded adipose-derived stem cells (eASCs) at its expanded manufacturing facility in Madrid.
Novartis on Tuesday announced positive results from the Phase III PARADIGMS study, investigating the safety and efficacy of oral once-daily…
Biocartis Group got clearance for the Idylla Respiratory (IFV-RSV) Panel from the US Food and Drug Administration (FDA). Idylla Respiratory…
Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, step down as CEO in 2018, after eight years in position. To…